Document:

Exhibit 4.10

 

OID
PROMISSORY NOTE

 

	PRINCIPAL
    AMOUNT: $500,000	ISSUE DATE: March 5, 2020
	PURCHASE
    PRICE: $450,000	 
	ORIGINAL
    ISSUE DISCOUNT: $50,000	 

 

FOR
VALUE RECEIVED, the undersigned, SOVEREIGN PLASTICS, LLC, a Colorado limited liability company, having an address at
5000 Quorum Drive STE 400, Dallas, TX 75254 (the “Borrower”), hereby promises to pay to the order of MARK
VANDERBEEK, a Canadian citizen, having an address at Unit 105 – Benton Street, Kitchener, Ontario, Canada N2G 3H6 (the
“Lender”), the principal sum of

 

FIVE
HUNDRED THOUSAND DOLLARS and 00/100 ($500,000.00)

 

Any
amount of principal on this Note which is not paid on the or before the Maturity Date shall bear interest at the rate of fifteen
percent (15%) per annum from the Maturity Date until the same is paid (“Default Interest Rate”). All such payments
shall be made in lawful money of the United States of America to the Lender at the address shown above in immediately available
funds.

 

In
lieu of the accrual of interest on the outstanding principal amount hereof on any date prior to the Maturity Date, this Note carries
an original issue discount of $50,000 (the “OID”) thus the purchase price of this Note shall be $450,000, computed
as follow: $500,000 initial principal balance less the OID.

 

The
occurrence of an Event of Default shall entitle the Lender to accelerate the entire indebtedness hereunder and to take such action
as may be provided for in any other instrument or agreement evidencing and/or securing this Note.

 

The
Borrower, for itself and its legal representatives, successors and assigns, to the extent it may lawfully do so, hereby expressly
waives presentment, demand, protest, notice of protest, presentment for the purpose of accelerating maturity, diligence in collection,
and the benefit of any exemption under the homestead exemption laws, if any, any other exemption or insolvency laws, and consents
that the Lender may release or surrender, exchange or substitute any real or personal property or other collateral security now
held or which may hereafter be held as security for the payment of this Note, and may extend the time for payment or otherwise
modify the terms of payment of any part or the whole of the debt evidenced hereby without in any way affecting the liability of
the Borrower hereunder.

 

Notwithstanding
anything to the contrary contained herein, in no event shall the amount of interest paid or agreed to be paid hereunder exceed
the maximum amount of interest, which the Lender is permitted to receive under applicable law. If, from any circumstances whatsoever,
fulfillment of any provision hereof shall require a payment exceeding such maximum amount, then the obligation to be fulfilled
shall automatically be reduced to the limit of such validity and if, from any circumstances, the Lender should ever receive as
interest an amount which would exceed such maximum amount, such amount which would be excessive interest shall be applied to the
reduction of the principal balance evidenced hereby and not the payment of interest.

 

    1

     

    

 

No
failure or delay on the part of the Lender in exercising any right, power or remedy hereunder shall operate as a waiver thereof,
nor shall any single or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or
the exercise of any other right, power or remedy hereunder. The remedies of the Lender hereunder are cumulative and not exclusive
of any remedies provided by law or otherwise available to the Lender. This Note may not be amended, waived, discharged or terminated
orally, but only by a statement in writing signed by the party against whom enforcement of the amendment, waiver, discharge or
termination is sought. Any waiver or consent shall be effective only in the specific instance and for the specific purpose for
which given.

 

The
Borrower agrees to pay on demand all reasonable costs and expenses (including, without limitation, the reasonable fees and out-of-pocket
expenses of legal counsel) incurred by the Lender in connection with preserving, enforcing or exercising any rights or remedies
under this Note, whether or not legal action is instituted. Any fees, expenses or other charges which the Lender is entitled to
receive from the Borrower hereunder shall constitute an obligation of the Borrower pursuant to this Note, and shall, to the extent
actually paid by the Lender, bear interest until paid at the applicable rate set forth herein.

 

The
Borrower irrevocably submits to the exclusive jurisdiction of any New York court or any federal court sitting within the State
of New York over any suit, action or proceeding arising out of or relating to this Note. The Borrower irrevocably waives, to the
fullest extent permitted by law, any objection which they may now or hereafter have to the laying of venue of any such suit, action
or proceeding brought in such a court and any claim that any such suit, action or proceeding has been brought in an inconvenient
forum.

 

This
Note shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to its principles
of conflicts of laws.

 

THE
BORROWER HEREBY WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING TO WHICH IT IS A PARTY INVOLVING, DIRECTLY OR INDIRECTLY, ANY
MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY MANNER ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS NOTE
OR THE RELATIONSHIP ESTABLISHED HEREUNDER.

 

[Signature
page follows]

 

    2

     

    

 

IN
WITNESS WHEREOF, the Borrower and Guarantors have caused this Note to be executed under their seal by duly authorized officers
as of the date first above written.

 

	Witness:	SOVEREIGN
    PLASTICS, LLC
	 	A
    Colorado limited liability company

 

	/s/ Khayal Algosaibi-Jones	 	By: 	/s/
    Daniel L. Hodges
	Name: 	Khayal
    Algosaibi-Jones	 	 	Name:
    Daniel L. Hodges
	 	 	 	 	Its:
    Executive Chairman

 

	 	COMSOVEREIGN HOLDING CORP.,

a Nevada corporation

	 	 	 
	 	By:	/s/ Daniel
L. Hodges
	 	 	Name:
    Daniel L. Hodges
	 	 	Its:
    CEO & Chairman

 

	 	GUARANTOR
	 	 	 
	 	By: 	/s/
    Daniel L. Hodges
	 	 	Name:
    Daniel L. Hodges

 

	 	AGREED:

MARK VANDERBEEK

	 	Lender
	 	 	 
	 	By:	/s/ Mark Vanderbeek
	 	 	Name: Mark Vanderbeek

 

[Signature
Page to Promissory Note dated March 5, 2020]

 

 

3Exhibit
10.32

 

STOCK
AGREEMENT

 

This
STOCK AGREEMENT (“Agreement”) is entered into as of March 5, 2020, by and among COMSOVEREIGN HOLDING CORP.,
a Nevada corporation (“COMSovereign”) and Mark Vanderbeek, a Canadian resident and citizen, (“Lender”).

 

WHEREAS,
COMSovereign has arranged and will benefit directly and indirectly from a loan being provided to COMSovereign’s subsidiary,
Sovereign Plastics LLC, by the Lender in the principal amount of up to FIVE HUNDRED THOUSAND DOLLARS and 00/100 ($500,000.00)
pursuant to that certain OID Promissory Note of even date herewith by and between COMSovereign, as parent, Sovereign Plastics,
LLC, as borrower, and the Lender, as lender (hereinafter the “Note”); and

 

WHEREAS,
as a condition to the agreement of the Lender entering into the Note and the making of the requested Term Loan thereunder, as
further consideration for Lender making the Term Loan, COMSovereign, agreed, on the day of the closing of the Term Loan pursuant
to the Note, to sell and issue to Lender Fifty-Thousand (50,000) shares of the common stock of COMSovereign for the purchase price
of One Cent ($0.01) per share (the “Shares”).

 

NOW,
THEREFORE, in consideration of the premises and as further consideration for Lender making the Term Loan and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, COMSovereign and Lender agree as follows:

 

1. Delivery
of Shares. Upon the date of the closing of the Term Loan contemplated by the Note, Lender shall pay COMSovereign the
amount of $500.00 as payment for the Shares. COMSovereign shall issue and deliver the shares in electronic form into the Lenders
book-entry account at the transfer agency. The Shares shall be validly issued, unencumbered and non-assessable.

 

2. Representations
and Warranties of COMsovereign. COMSovereign represents and warrants to Lender that COMSovereign is duly authorized
and has obtained all necessary consents and approvals required by its corporate governance documents, required by applicable law,
or, necessary to be obtained from any governmental authorities and third parties which are required for the valid and binding
issuance and delivery of the Shares by COMSovereign to Lender.

 

3. Acknowledgments.
COMSovereign hereby acknowledges that (i) a breach of this Agreement shall be a breach of and an event of default under the Note,
and, (ii) the Shares shall be consideration earned by Lender upon Lender entering into the Note.

 

4. Governing
Law. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York,
without regard to principles of conflicts of law. Jurisdiction shall lie in New York with respect to all disputes, controversies,
claims, actions and similar proceedings arising under this Agreement and the performance hereof by either party.

 

SIGNATURE
PAGE FOLLOWS

 

     

     

    

 

IN
WITNESS WHEREOF, each COMSovereign and Lender have each caused their duly authorized officer, member or manager, as applicable,
to be duly executed as of the date first above written.

 

	 	COMSOVEREIGN
    HOLDING CORP.
	 	 
	 	By: 	/s/ Daniel L. Hodges
	 	 	Name: Daniel L. Hodges
	 	 	Title: Chairman and CEO

 

	 	MARK
    VANDERBEEK
	 	 
	 	By: 	/s/
    Mark Vanderbeek
	 	 	Name: Mark
    VanderbeekEX-4.3

 Exhibit 4.3 

FORM OF DEBT SECURITY 
 [Face of
Security] 
 AEGLEA BIOTHERAPEUTICS, INC. 

[If applicable, insert—FOR PURPOSES OF THE ORIGINAL ISSUE DISCOUNT PROVISIONS OF THE INTERNAL REVENUE CODE OF 1986, THE ISSUE PRICE OF
THIS SECURITY IS                 % OF ITS PRINCIPAL AMOUNT AT STATED MATURITY SET FORTH BELOW (ITS “PRINCIPAL AMOUNT”), THE AMOUNT OF ORIGINAL ISSUE DISCOUNT
IS                 % OF ITS PRINCIPAL AMOUNT, THE YIELD TO MATURITY IS                 %
AND THE ISSUE DATE IS                ] 
 [IF THE SECURITY
IS A GLOBAL SECURITY, INSERT—THIS NOTE IS A GLOBAL SECURITY. IT IS EXCHANGEABLE FOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY (AS HEREINAFTER DEFINED) OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES HEREINAFTER
DESCRIBED AND MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY
TO A SUCCESSOR OF THE DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.] 
  

			
	No.	  	$    
		  	CUSIP No.    

 Aeglea BioTherapeutics, Inc., a Delaware corporation (herein called the “Company”, which term
includes any successor corporation under the Indenture referred to on the reverse hereof), for value received, hereby promises to pay to, or registered assigns, the principal sum of
                 Dollars on                  [if Security is to bear interest prior to
maturity, insert—, and to pay interest thereon from                  or from the most recent Interest Payment Date to which interest has been paid or duly provided
for, semi-annually on                  and                  in each year, commencing
                , at the rate of                 % per annum, until the principal hereof
is paid or made available for payment [if applicable, insert—, provided that any principal and premium, and any such installment of interest, which is overdue shall bear interest at the rate
of                % per annum (to the extent that the payment of such interest shall be legally enforceable), from the dates such amounts are due until they are paid or
made available for payment, and such interest shall be payable on demand]]. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this
Security (or one or more predecessor Securities) is registered at the close of business on the record date for such interest, which shall be the                  or
                 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly
provided for will forthwith cease to be payable to the Holder on such record date and may either be paid to the Person at the time this Security (or one or more predecessor Securities) is registered at the close of business on a special record date
for the payment of such defaulted interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such special record date, or be paid at any time in any other lawful manner
not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. [If the Security is not
to bear interest prior to maturity, insert—The principal of this Security shall not bear interest except in the case of a default in payment of principal upon acceleration, upon redemption or at Stated Maturity and in such case the overdue
principal and any overdue premium shall bear interest at the rate of                 % per annum (to the extent that the payment of such interest shall be legally
enforceable), from the dates such amounts are due until they are paid or made available for payment. Interest on any overdue principal or premium shall be payable on demand. [Any such interest on overdue principal or premium which is not paid on
demand shall bear interest at the rate of                 % per annum (to the extent that the payment of such interest on interest shall be legally enforceable), from
the date of such demand until the amount so demanded is paid or made available for payment. Interest on any overdue interest shall be payable on demand.]]. 

Payment of the principal of (and premium, if any, on) and [any such] interest on this Security will be made at the office or agency of the
Company maintained for that purpose in                  in such coin or currency of [the United States of America] as at the time of payment is legal tender for payment
of public and private debts[; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the register of the Security maintained
by the Registrar]. 
 Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further
provisions shall for all purposes have the same effect as if set forth at this place. 

  
 1 

 Unless the certificate of authentication hereon has been manually executed by or on behalf
of the Trustee under the Indenture referred to on the reverse hereof, this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal. 

 

							
	Dated:	 		 	Aeglea BioTherapeutics, Inc.
				
		 		 	By	 	 
		 		 		 	[Title]

  

	
	 Attest and Countersign

	  

	Secretary

  
 2 

 [Reverse of Security.] 

AEGLEA BIOTHERAPEUTICS, INC. 

This Security is one of a duly authorized issue of securities of the Company (herein called the “Securities”), issued and to be
issued in one or more series under an Indenture dated as of                 , (herein called the “Indenture,” which term shall have the meaning assigned to it
in such instrument), between the Company and                 , as trustee (herein called the “Trustee”, which term includes any successor trustee under the
Indenture), to which the Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations or rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the
Securities and of the terms upon which the Securities are, and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof [, limited in aggregate principal amount to
$                ]. 
 [If the Security is to be
subordinated, insert—The indebtedness evidenced by this Security is, to the extent and in the manner set forth in the Indenture, expressly subordinated and subject in right of payment to the prior payment in full of all senior Indebtedness (as
defined in the Indenture) of the Company. This Security is issued subject to such provisions of the Indenture, and each Holder of this Security, by accepting the same, agrees to and shall be bound by such provisions and authorizes and directs the
Trustee on the Holder’s behalf to take such action as may be necessary or appropriate to acknowledge or effectuate such subordination as provided in the Indenture and appoints the Trustee such Holder’s attorney-in-fact for any and all such purposes.] 
 The Securities of this series are subject to
redemption upon not less than 30 days’, and no more than 60 days, notice provided in the manner set forth in the Indenture, [(1) on in any year commencing with the year and ending with the year at the Redemption Price (as indicated below)
equal to 100% of the principal amount, and (2)] at any time [on or after], as a whole or in part, at the election of the principal the following Redemption Prices (expressed as percentages of the principal amount, as indicated below): If redeemed
[on or before ,                 %, and if redeemed] during the 12-month period beginning of the years indicated, 

 

													
	 Year
	  	Redemption Price	 	  	Year	 	  	Redemption Price	 
		  				  				  			
		  				  				  			
		  				  				  			

 and thereafter at a Redemption Price equal to    % of the principal amount together in the case of any
such redemption with accrued interest to the Redemption Date, but interest installments whose Stated Maturity is on or prior to such Redemption Date will be payable to the Holders of such Securities of record at the close of business on the relevant
record dates referred to on the face hereof, all as provided in the Indenture. 
 [If the Security is to be redeemable in part,
insert—In the event of redemption of this Security in part only, a new Security or Securities of this series for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof.] 

[If the Security is to be subject to repayment at the option of the Holder, insert—To be repaid at the option of the Holder, the Company
must receive this Security, with the form of “Option to Elect Repayment” hereon duly completed, at an office or agency of the Company maintained for that purpose in (or at such other place of which the Company shall from time to time
notify the Holder of this Security) not less than                nor more
than                days prior to the Repayment Date (as defined therein). The exercise of the repayment option by the Holder shall be irrevocable.] 

[If the Security is not to be subject to redemption at the option of the Company, insert—The Securities are not redeemable at the option
of the Company prior to Maturity.] 
 [If the Security is not to be an Original Issue Discount Security, insert—If an Event of Default
with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture.] 

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company and the rights of the Holders of the Securities of each Series under the Indenture to be affected at any time by the Company with the consent of the Holders of not less than a majority in aggregate principal amount of the Securities
then outstanding of each Series to be affected. 

  
 3 

 The Indenture also contains provisions permitting the Holders of a majority in principal amount of the
Securities of any Series then outstanding, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past Defaults or Events of Default with respect to such
Series under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the
registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent of waiver is made upon this Security. 

As provided in and subject to the provisions of the indenture, the Holder of this Security shall not have the right to institute any
proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect to
the Securities of this series, the Holders of not less than 25% in aggregate principal amount of the Securities of this series then outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of
Default as Trustee and offered the Trustee indemnity reasonably satisfactory to the Trustee, and the Trustee shall not have received from the Holders of a majority in aggregate principal amount of Securities of this series then outstanding a
direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this
Security for the enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 

No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of (and premium, if any, on) and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 

[If the Security is to be in registered form, insert—As provided in the Indenture and subject to certain limitations therein set forth,
the transfer of this Security is registrable in the register of the Registrar, upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of (and premium, if any, on) and
interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and,
thereupon one or more new Securities of this series, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees.] 

[The Securities of this series are issuable only in registered form in denominations of
$                [and any integral multiple] [or increments of $                in
excess] thereof. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series of a different authorized denomination,
as requested by the Holder surrendering the same.] 
 [No service charge shall be made for any such registration of transfer or exchange,
but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.] 

[Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.] 

[If the Security is a Global Security, insert—“Global Security” and “Global Securities” means a Security or
Securities evidencing all or a part of a series of Securities, issued to the Depositary (as hereinafter defined) for such Series or its nominee, and registered in the name of such Depositary or its nominee. “Depositary” means, with
respect to the Securities of any series issuable or issued in whole or in part in the form of one or more Global Securities, the person designated as the Depositary by the Company. 

No holder of any beneficial interest in this Security held on its behalf by a Depositary or a nominee of such Depositary shall have any rights
under the Indenture with respect to such Global Security, and such Depositary or nominee may be treated by the Company, the Trustee, and any agent of the Company or the Trustee as the owner of such Global Security for all purposes whatsoever.
Notwithstanding the foregoing, nothing herein shall impair, as between a Depositary and such holders of beneficial interests, the operation of customary practices governing the exercise of the rights of the Depositary as Holder of any Security. 

This Security is exchangeable, in whole but not in part, for Securities registered in the names of Persons other than the Depositary or its
nominee or in the name of a successor to the Depositary or a nominee of such successor depositary only if (i) the Depositary notifies the Company that it is unwilling or unable to continue as Depositary for this Note or if at any time such
Depositary ceases to be a clearing agency registered under the Securities Exchange Act of 1934, as amended, and, in either case, a successor depositary is not appointed by the Company within 90 days, (ii) the Company in its discretion at any
time determines not to have all of the Securities of this series represented by one or more Global Security or Securities and notifies the Trustee thereof, or (iii) an Event of Default has occurred and is continuing with respect to the
Securities of this series. If this Security is exchangeable pursuant to the preceding sentence, it shall be exchangeable for Securities issuable in authorized denominations and registered in such names as the

  
 4 

 
Depositary holding this Security shall direct. Subject to the foregoing, this Security is not exchangeable, except for a Security or Securities of the same aggregate denominations to be
registered in the name of such Depositary or its nominee or in the name of a successor to the Depositary or a nominee of such successor depositary.] 

[The Indenture entitles Holders to receive annual reports with respect to the Trustee’s eligibility and qualifications to serve as
Trustee by filing their names and addresses with the Trustee for that purpose within two years preceding and mailing of any such annual report.] 

No recourse shall be had for the payment of the principal of (and premium, if any, on) or interest on this Security, or for any claim based
hereon, or otherwise in respect hereof, or based on or in respect of the Indenture of any indenture supplemental thereto, against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or any successor
corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise, all such liability being, by the acceptance hereof and as part of the consideration for the issue
hereof, expressly waived and released. 
 All terms used in this Security which are defined in the Indenture shall have the meanings
assigned to them in the Indenture. 
 This Security, including without limitation the obligation of the Company contained herein to pay the
principal of (and premium, if any, on) and interest on this Security in accordance with the terms hereof and of the Indenture, shall be construed in accordance with and governed by the laws of the State of New York. 

[Trustee’s Certificate of Authentication.] 

This is one of the Securities of the series designated herein referred to in the within-mentioned Indenture. 

 

			
	                                    
                                        , 
as
	[Authenticating Agent for] the Trustee
		
	 By
	 	  

		 	Authorized Officer

  
 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]